S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

OPK Opko Health Inc

1.28

-0.02 (-1.54%)

After Hours

Last Updated: 16:38:26

Delayed by 15 minutes

Notice of Effectiveness (effect)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
NOTICE OF EFFECTIVENESS

Effective Date:	July 17, 2015
Form:	S-4

CIK:	0000944809
Company Name:	Opko Health, Inc.
File Number:	333-205480

Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Opko Health Charts.

Opko Health (NASDAQ:OPK)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Opko Health Charts.

Opko Health, Inc. News

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
Friday 3 May 2024 (12 hours ago) • GlobeNewswire Inc.

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Thursday 28 March 2024 (1 month ago) • PR Newswire (US)

Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
Wednesday 20 March 2024 (1 month ago) • GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st
Wednesday 28 February 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.

Form PRE 14A - Other preliminary proxy statements
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)

More Opko Health, Inc. News Articles

Marketing Worldwide (PK)

Bell Buckle (PK)

Yuenglings Ice Cream (PK)

RespireRx Pharmaceuticals (PK)

Moon Equity (PK)

Ubiquitech Software (PK)

Umbra Applied Technologies (PK)

Brookmount Explorations (PK)

Global Developments (PK)

Astra Energy (QB)

Clean Vision (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions